PROM1 and neoplasm: In addition, we determined that CD133 expression was elevated in metastatic tissues of patients who developed resistance to HT as compared with their matched primary tumours using immunohistochemical analysis (Fig. 1b, HTR-Met, P=0.031; Wilcoxon exact test and Supplementary Table 1).